TY - JOUR
T1 - Patterns of restenosis after drug-eluting stent implantation
T2 - Insights from a contemporary and comparative analysis of sirolimus- and paclitaxel-eluting stents
AU - Corbett, Simon J.
AU - Cosgrave, John
AU - Melzi, Gloria
AU - Babic, Rade
AU - Biondi-Zoccai, Giuseppe G L
AU - Godino, Cosmo
AU - Morici, Nuccia
AU - Airoldi, Flavio
AU - Michev, Iassen
AU - Montorfano, Matteo
AU - Sangiorgi, Giuseppe M.
AU - Bonizzoni, Erminio
AU - Colombo, Antonio
PY - 2006/10
Y1 - 2006/10
N2 - Aim: To evaluate patterns of restenosis following implantation of sirolimus-eluting stent (SES) and paclitaxel-eluting stent (PES) in comparable unselected lesions. Methods and results: We have identified all episodes of restenosis after SES or PES implantation in our institutions between March 2003 and March 2005. Restenosis pattern was classified as focal, diffuse, proliferative, or occlusive. The position of focal restenosis was also categorized as proximal, in-stent, distal, or multi-focal. We have characterized 150 and 149 restenotic lesions in SES and PES groups, respectively. The incidence of diffuse and occlusive restenosis was significantly higher in PES than in SES (47.6 vs. 27.0%, P
AB - Aim: To evaluate patterns of restenosis following implantation of sirolimus-eluting stent (SES) and paclitaxel-eluting stent (PES) in comparable unselected lesions. Methods and results: We have identified all episodes of restenosis after SES or PES implantation in our institutions between March 2003 and March 2005. Restenosis pattern was classified as focal, diffuse, proliferative, or occlusive. The position of focal restenosis was also categorized as proximal, in-stent, distal, or multi-focal. We have characterized 150 and 149 restenotic lesions in SES and PES groups, respectively. The incidence of diffuse and occlusive restenosis was significantly higher in PES than in SES (47.6 vs. 27.0%, P
KW - Paclitaxel
KW - Restenosis
KW - Sirolimus
KW - Stent
UR - http://www.scopus.com/inward/record.url?scp=33749027753&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=33749027753&partnerID=8YFLogxK
U2 - 10.1093/eurheartj/ehl229
DO - 10.1093/eurheartj/ehl229
M3 - Article
C2 - 16952923
AN - SCOPUS:33749027753
VL - 27
SP - 2330
EP - 2337
JO - European Heart Journal
JF - European Heart Journal
SN - 0195-668X
IS - 19
ER -